Debora Martínez

Publicacions destacades

• Gene expression profiles of breast cancer metastasis according to organ site

  Autors:

  Braso-Maristany, Fara; Pare, Laia; Chic, Nuria; Martinez-Saez, Olga; Pascual, Tomas;

  (...)

  Adamo, Barbara; Moreno, Reinaldo; Vidal, Maria; Munoz, Montserrat; Prat, Aleix.

  Veure llistat complet d'autors

  Referència: Molecular Oncology 2022.

• Case Report: A Case Study Documenting the Activity of Atezolizumab in a PD-L1-Negative Triple-Negative Breast Cancer

  Autors:

  Braso-Maristany, Fara; Sanso, Miriam; Chic, Nuria; Martinez, Debora; Gonzalez-Farre, Blanca;

  (...)

  Peg, Vicente; Saura, Cristina; Munoz, Montserrat; Prat, Aleix; Vivancos, Ana.

  Veure llistat complet d'autors

  Referència: Frontiers In Oncology 2021.

• Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy: ER activity in pre-menopausal HR+ breast cancer during CT

  Autors:

  Chic, Nuria; Schettini, Francesco; Braso-Maristany, Fara; Sanfeliu, Esther; Adamo, Barbara;

  (...)

  Munoz, Montserrat; Perou, Charles M; Pascual, Tomas; Bellet, Meritxell; Prat, Aleix.

  Veure llistat complet d'autors

  Referència: Ebiomedicine 2021.

• Identification of cell surface targets for CAR-T cell therapies and antibody-drug conjugates in breast cancer

  Autors:

  Schettini, F; Barbao, P; Braso-Maristany, F; Galvan, P; Martinez, D;

  Pare, L; De Placido, S; Prat, A; Guedan, S.

  Referència: Esmo Open 2021.

• Correlative Biomarker Analysis of Intrinsic Subtypes and Efficacy Across the MONALEESA Phase III Studies

  Autors:

  Prat, A; Chic, N; Martínez-Sáez, O; Brasó-Maristany, F; Paré, L;

  (...)

  Solovieff, N; Lteif, A; Babbar, N; Su, F; Taran, T.

  Veure llistat complet d'autors

  Referència: Journal Of Clinical Oncology 2021.

• Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy

  Autors:

  Martinez-Saez, Olga; Pascual, Tomas; Braso-Maristany, Fara; Chic, Nuria; Gonzalez-Farre, Blanca;

  (...)

  Salvador, Fernando; Ciruelos, Eva M; Faull, Iris; Odegaard, Justin I; Prat, Aleix.

  Veure llistat complet d'autors

  Referència: Npj Breast Cancer 2021.

• Palbociclib and trastuzumab in HER2-positive advanced breast cancer: Results from the phase II SOLTI-1303 PATRICIA trial

  Autors:

  Ciruelos E; Villagrasa P; Pascual T; Oliveira M; Pernas S;

  (...)

  Galván P; Canes J; Nuciforo P; Gonzalez X; Prat A .

  Veure llistat complet d'autors

  Referència: Clinical Cancer Research 2020.

• ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer

  Autors:

  Griguolo, Gaia; Braso-Maristany, Fara; Gonzalez-Farre, Blanca; Pascual, Tomas; Chic, Nuria;

  (...)

  Dieci, Maria Vittoria; Conte, Pierfranco; Harbeck, Nadia; Guarneri, Valentina; Prat, Aleix.

  Veure llistat complet d'autors

  Referència: Cancers 2020.

• Frequency and spectrum of PIK3CA somatic mutations in breast cancer

  Autors:

  Martinez-Saez, Olga; Chic, Nuria; Pascual, Tomas; Adamo, Barbara; Vidal, Maria;

  (...)

  Galvan, Patricia; Rodriguez, Ana Belen; Martinez, Antonio; Munoz, Montserrat; Prat, Aleix.

  Veure llistat complet d'autors

  Referència: Breast Cancer Research 2020.

• Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial

  Autors:

  Gavilá J; Oliveira M; Pascual T; Perez-Garcia J; Gonzàlez X;

  (...)

  Marín-Aguilera M; Martínez D; Quero JC; Llombart-Cussac A; Prat A .

  Veure llistat complet d'autors

  Referència: Bmc Medicine 2019.